Target intelligence / Profile preview

Intracellular free calcium (Ca²⁺ (or Ca2+, depending on usage), but no formal abbreviation unique to "intracellular free calcium" distinct from "calcium")

Target
Ca²⁺ (or Ca2+, depending on usage), but no formal abbreviation unique to "intracellular free calcium" distinct from "calcium"
Molecular classification
Other (intracellular ion pool; not a protein, enzyme, receptor, or classic drug target class), Second messenger
01

Overview

Intracellular free calcium refers to the pool of unbound calcium ions (Ca²⁺) present within the cytosol and organelles such as the endoplasmic reticulum and mitochondria of living cells[3][4][5][1]. Calcium acts as an essential second messenger, transducing signals that regulate a vast range of cellular processes such as muscle contraction, neurotransmitter release, gene transcription, cell division, and programmed cell death[3][4][5]. The concentration of free calcium in the cytosol is tightly regulated—typically around 10–100 nM under resting conditions, in stark contrast to much higher extracellular concentrations (~2 mM)[3][8]. Changes in intracellular free calcium are generated by highly orchestrated release from internal stores or influx through specialized channels. Rather than being a single molecular target, intracellular free calcium represents a dynamic and fundamental cellular parameter, making it critical for physiology and disease but not a discrete druggable target itself[1][3][4][5][8].

Other names
cytosolic free calciumcytosolic calciumintracellular calcium ion concentration[Ca²⁺]_i (typical biochemical shorthand)free Ca²⁺ (intracellular)cellular calcium
02

Mechanism of action

Drugs affect the amplitude, duration, or frequency of intracellular free calcium signals by modulating channels (blockers or activators), pumps (inhibitors), or signaling pathways that trigger Ca²⁺ flux across cellular membranes[2][6][4][10]. - Modulation of GPCR–phospholipase C–IP₃ pathway affects calcium release from ER[2][4][8]. - Inhibiting calcineurin prevents calcium-dependent activation of specific transcription factors (e.g., NFAT)[2][10].

03

Biological functions

Signal transductionMuscle contractionNeurotransmitter releaseCell proliferation and differentiationApoptosis (programmed cell death)Gene transcriptionCell cycle regulationMetabolism (including glycolysis, gluconeogenesis)Immune responseExocytosis/endocytosisFertilization
04

Disease associations

Neurodegenerative disease (e.g., Ca²⁺ toxicity in neurons)Cardiovascular disease (arrhythmias, hypertension, heart failure)Muscle disorders (myopathies, dystrophies)Cancer (proliferation and apoptosis dysregulation)InflammationOther (general relevance to cell injury, ischemia, metabolic, and genetic disorders)
05

Safety considerations

Dysregulation of intracellular free calcium can lead to cytotoxicity, cell death (necrosis or apoptosis)Sustained elevation of free calcium is a common pathway in excitotoxicity, cardiac arrhythmias, and metabolic cell injuryDrugs influencing calcium homeostasis (e.g., channel blockers) may cause side effects such as hypotension, bradycardia, arrhythmias, or muscle weakness.
06

Interacting drugs

Calcium channel blockers (nifedipine, verapamil, diltiazem)

5 more in the full profile.

07

Biomarkers

Intracellular calcium imaging/fluorescent indicators (e.g., Fura-2, Fluo-4) are used as biomarkers of cellular activation or toxicity in researchNo clinically used static biomarker for "intracellular free calcium," but dynamic measurement is common in experimental and diagnostic settings.

Beyond the preview

Go deeper on Intracellular free calcium (Ca²⁺ (or Ca2+, depending on usage), but no formal abbreviation unique to "intracellular free calcium" distinct from "calcium").

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intracellular free calcium (Ca²⁺ (or Ca2+, depending on usage), but no formal abbreviation unique to "intracellular free calcium" distinct from "calcium").

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call